These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 32044391)

  • 21. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment.
    Low A; Ng KP; Chander RJ; Wong B; Kandiah N
    J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral Blood Biomarkers Coupled with the Apolipoprotein E4 Genotype Are Strongly Associated with Semantic and Episodic Memory Impairments in Elderly Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease.
    Supasitthumrong T; Tunvirachaisakul C; Aniwattanapong D; Tangwongchai S; Chuchuen P; Tawankanjanachot I; Snabboon T; Hemrungrojn S; Carvalho AF; Maes M
    J Alzheimers Dis; 2019; 71(3):797-811. PubMed ID: 31424390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Impact of APOE ɛ4 in Alzheimer's Disease Differs According to Age.
    Kim J; Park S; Yoo H; Jang H; Kim Y; Kim KW; Jang YK; Lee JS; Kim ST; Kim S; Lee JM; Ki CS; Na DL; Seo SW; Kim HJ
    J Alzheimers Dis; 2018; 61(4):1377-1385. PubMed ID: 29376853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Personality factors and cerebral glucose metabolism in community-dwelling older adults.
    Sohrabi HR; Goozee K; Weinborn M; Shen K; Brown BM; Rainey-Smith SR; Salvado O; Taddei K; Bucks RS; Maruff P; Laws SM; Lenzo N; Laws M; DeYoung C; Speelman C; Laske C; Ames D; Savage G; Martins RN
    Brain Struct Funct; 2020 Jun; 225(5):1511-1522. PubMed ID: 32342225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
    Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
    JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
    Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
    Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network.
    Bussy A; Snider BJ; Coble D; Xiong C; Fagan AM; Cruchaga C; Benzinger TLS; Gordon BA; Hassenstab J; Bateman RJ; Morris JC;
    Neurobiol Aging; 2019 Mar; 75():42-50. PubMed ID: 30530186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease.
    Pievani M; Galluzzi S; Thompson PM; Rasser PE; Bonetti M; Frisoni GB
    Neuroimage; 2011 Apr; 55(3):909-19. PubMed ID: 21224004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dementia risk and dynamic response to exercise: A non-randomized clinical trial.
    Vidoni ED; Morris JK; Palmer JA; Li Y; White D; Kueck PJ; John CS; Honea RA; Lepping RJ; Lee P; Mahnken JD; Martin LE; Billinger SA
    PLoS One; 2022; 17(7):e0265860. PubMed ID: 35802628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention.
    Keeney JT; Ibrahimi S; Zhao L
    J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal APOE4- and amyloid-dependent changes in the blood transcriptome in cognitively intact older adults.
    Luckett ES; Zielonka M; Kordjani A; Schaeverbeke J; Adamczuk K; De Meyer S; Van Laere K; Dupont P; Cleynen I; Vandenberghe R
    Alzheimers Res Ther; 2023 Jul; 15(1):121. PubMed ID: 37438770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein e4 affects topographical changes in hippocampal and cortical atrophy in Alzheimer's disease dementia: a five-year longitudinal study.
    Kim YJ; Cho H; Kim YJ; Ki CS; Chung SJ; Ye BS; Kim HJ; Kim JH; Kim ST; Lee KH; Jeon S; Lee JM; Chin J; Kim JH; Na DL; Seong JK; Seo SW
    J Alzheimers Dis; 2015; 44(4):1075-85. PubMed ID: 25391384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Damage of the temporal lobe and APOE status determine neural compensation in mild cognitive impairment.
    Prieto Del Val L; Cantero JL; Baena D; Atienza M
    Cortex; 2018 Apr; 101():136-153. PubMed ID: 29475078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Klotho-VS Heterozygosity With Risk of Alzheimer Disease in Individuals Who Carry APOE4.
    Belloy ME; Napolioni V; Han SS; Le Guen Y; Greicius MD;
    JAMA Neurol; 2020 Jul; 77(7):849-862. PubMed ID: 32282020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased Carbohydrate Intake is Associated with Poorer Performance in Verbal Memory and Attention in an APOE Genotype-Dependent Manner.
    Gardener SL; Rainey-Smith SR; Sohrabi HR; Weinborn M; Verdile G; Fernando WMADB; Lim YY; Harrington K; Burnham S; Taddei K; Masters CL; Macaulay SL; Rowe CC; Ames D; Maruff P; Martins RN;
    J Alzheimers Dis; 2017; 58(1):193-201. PubMed ID: 28387666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DHA brain uptake and APOE4 status: a PET study with [1-
    Yassine HN; Croteau E; Rawat V; Hibbeln JR; Rapoport SI; Cunnane SC; Umhau JC
    Alzheimers Res Ther; 2017 Mar; 9(1):23. PubMed ID: 28335828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of APOE ε4 Genotype on Metabolic Biomarkers in Aging and Alzheimer's Disease.
    Morris JK; Uy RAZ; Vidoni ED; Wilkins HM; Archer AE; Thyfault JP; Miles JM; Burns JM
    J Alzheimers Dis; 2017; 58(4):1129-1135. PubMed ID: 28550261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human apolipoprotein E4 modulates the expression of Pin1, Sirtuin 1, and Presenilin 1 in brain regions of targeted replacement apoE mice.
    Lattanzio F; Carboni L; Carretta D; Rimondini R; Candeletti S; Romualdi P
    Neuroscience; 2014 Jan; 256():360-9. PubMed ID: 24161275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyloid-associated depression and ApoE4 allele: longitudinal follow-up for the development of Alzheimer's disease.
    Qiu WQ; Zhu H; Dean M; Liu Z; Vu L; Fan G; Li H; Mwamburi M; Steffens DC; Au R
    Int J Geriatr Psychiatry; 2016 Mar; 31(3):316-22. PubMed ID: 26250797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden.
    Zwan MD; Villemagne VL; Doré V; Buckley R; Bourgeat P; Veljanoski R; Salvado O; Williams R; Margison L; Rembach A; Macaulay SL; Martins R; Ames D; van der Flier WM; Ellis KA; Scheltens P; Masters CL; Rowe CC
    J Alzheimers Dis; 2016; 49(4):1115-22. PubMed ID: 26639956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.